These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29784119)

  • 61. Diagnosis of venous disease with duplex ultrasound.
    Malgor RD; Labropoulos N
    Phlebology; 2013 Mar; 28 Suppl 1():158-61. PubMed ID: 23482553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Iliac-caval stenting in the obese.
    Raju S; Darcey R; Neglén P
    J Vasc Surg; 2009 Nov; 50(5):1114-20. PubMed ID: 19878789
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Iliac-femoral venous stenting for lower extremity venous stasis symptoms.
    Alhalbouni S; Hingorani A; Shiferson A; Gopal K; Jung D; Novak D; Marks N; Ascher E
    Ann Vasc Surg; 2012 Feb; 26(2):185-9. PubMed ID: 22018502
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Poterucha JT; Taggart NW; Johnson JN; Cannon BC; Cabalka AK; Hagler DJ; Dearani JA; Cetta F
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):306-314. PubMed ID: 27785879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term patency of venous sinus stents for idiopathic intracranial hypertension.
    Ducruet AF; Crowley RW; McDougall CG; Albuquerque FC
    J Neurointerv Surg; 2014 Apr; 6(3):238-42. PubMed ID: 23585640
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ultra-low profile Ovation device: is it the definitive solution for EVAR?
    de Donato G; Setacci F; Sirignano P; Galzerano G; Borrelli MP; di Marzo L; Setacci C
    J Cardiovasc Surg (Torino); 2014 Feb; 55(1):33-40. PubMed ID: 24356044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bioresorbable stents: Current and upcoming bioresorbable technologies.
    Ang HY; Bulluck H; Wong P; Venkatraman SS; Huang Y; Foin N
    Int J Cardiol; 2017 Feb; 228():931-939. PubMed ID: 27912202
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patency and Clinical Outcome After Stent Placement for Chronic Obstruction of the Inferior Vena Cava.
    Grøtta O; Enden T; Sandbæk G; Gjerdalen GF; Slagsvold CE; Bay D; Kløw NE; Rosales A
    Eur J Vasc Endovasc Surg; 2017 Nov; 54(5):620-628. PubMed ID: 28797661
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.
    Wressnegger A; Kaider A; Funovics MA
    Trials; 2017 Dec; 18(1):594. PubMed ID: 29237489
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stenting is the "Method-of-Choice" to treat iliofemoral venous outflow obstruction.
    Neglén P
    J Endovasc Ther; 2009 Aug; 16(4):492-3. PubMed ID: 19702344
    [No Abstract]   [Full Text] [Related]  

  • 71. Thoracic endovascular aortic repair: are we approaching total endovascular solutions for thoracic aortic disease?
    Shah A; Bombien R; Khoynezhad A
    Multimed Man Cardiothorac Surg; 2014; 2014():. PubMed ID: 25012992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Results of endovascular treatment of obstructive lesions of veins of the iliofemoral segment].
    Pokrovskiĭ AV; Ignat'ev IM; Gradusov EG
    Angiol Sosud Khir; 2018; 24(2):57-68. PubMed ID: 29924776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux.
    Proebstle TM; Kleis-Fischer B; Möhler T; Goeckeritz O; Franklin IJ; Almeida JI
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):41-47.e1. PubMed ID: 28993089
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanical characteristics of venous stents to overcome challenges of venous outflow obstruction.
    Lim CS; Black SA
    Int Angiol; 2022 Jun; 41(3):240-248. PubMed ID: 35138073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In situ fenestrations for the aortic arch and visceral segment: advances and challenges.
    Riga CV; McWilliams RG; Cheshire NJ
    Perspect Vasc Surg Endovasc Ther; 2011 Sep; 23(3):161-5. PubMed ID: 21502107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anatomical Suitability of the Zenith Off-the-Shelf (p-Branch) Endograft in Juxtarenal Aortic Aneurysms Previously Treated Using the Chimney Technique.
    Schroeder M; Donas KP; Stavroulakis K; Stachmann A; Torsello G; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):223-229. PubMed ID: 28042763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current knowledge on E-vita abdominal endograft.
    Moulakakis KG; Avgerinos ED; Giannakopoulos T; Papapetrou A; Brountzos EN; Liapis CD
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):533-8. PubMed ID: 20671636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Urgent endovascular treatment of symptomatic or contained ruptured aneurysms with modified stent grafts.
    Oderich GS; Farber MA; Sanchez LA
    Perspect Vasc Surg Endovasc Ther; 2011 Sep; 23(3):186-94. PubMed ID: 21810819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.